Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (171-180 of 395) with videos related to

Pageof 40
Sort By:
JAMA Neurology|May 1, 2014
Emerging β-amyloid pathology and accelerated cortical atrophyNiklas Mattsson, Philip S Insel, Rachel Nosheny, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2022
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performanceAlexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, et al.
Brain : a Journal of Neurology|January 16, 2025
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-betaClaudia Cicognola, Gemma Salvadó, Ruben Smith, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's diseasePhilip S Insel, Niklas Mattsson, R Scott Mackin, et al.
International Journal of Geriatric Psychiatry|June 29, 2018
Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairmentMitzi M Gonzales, Philip S Insel, Craig Nelson, et al.
Frontiers in Aging Neuroscience|March 29, 2011
Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative DiseasesChristoffer Rosén, Niklas Mattsson, Per M Johansson, et al.
Neurology|May 14, 2026
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive DeclineMaría Rivera Sánchez, Sophie E Mastenbroek, Shorena Janelidze, et al.
Brain : a Journal of Neurology|March 15, 2014
Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairmentNiklas Mattsson, Duygu Tosun, Philip S Insel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2015
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDemChristoffer Rosén, Bahman Farahmand, Tobias Skillbäck, et al.
Pediatric Neurology|July 6, 2013
Cerebrospinal fluid brain injury biomarkers in children: a multicenter studyPashtun Shahim, Niklas Darin, Ulf Andreasson, et al.
Pageof 40

Showing results (171-180 of 395) with videos related to

Sort By:
Pageof 40
JAMA Neurology|May 1, 2014
Emerging β-amyloid pathology and accelerated cortical atrophyNiklas Mattsson, Philip S Insel, Rachel Nosheny, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2022
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performanceAlexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, et al.
Brain : a Journal of Neurology|January 16, 2025
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-betaClaudia Cicognola, Gemma Salvadó, Ruben Smith, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's diseasePhilip S Insel, Niklas Mattsson, R Scott Mackin, et al.
International Journal of Geriatric Psychiatry|June 29, 2018
Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairmentMitzi M Gonzales, Philip S Insel, Craig Nelson, et al.
Frontiers in Aging Neuroscience|March 29, 2011
Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative DiseasesChristoffer Rosén, Niklas Mattsson, Per M Johansson, et al.
Neurology|May 14, 2026
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive DeclineMaría Rivera Sánchez, Sophie E Mastenbroek, Shorena Janelidze, et al.
Brain : a Journal of Neurology|March 15, 2014
Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairmentNiklas Mattsson, Duygu Tosun, Philip S Insel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2015
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDemChristoffer Rosén, Bahman Farahmand, Tobias Skillbäck, et al.
Pediatric Neurology|July 6, 2013
Cerebrospinal fluid brain injury biomarkers in children: a multicenter studyPashtun Shahim, Niklas Darin, Ulf Andreasson, et al.
Pageof 40